Health Care Innovation
Commentary
Trump And Clinton’s Healthcare Debate Was No Contest
Donald Trump’s penchant for brusque remarks came in handy during the second presidential debate, eight days ago. When the discussion turned to the president’s health law, the GOP candidate’s message was clear: “Obamacare is a disaster. You know it. We all know it.” Only Hillary’s own spouse put it better, ...
California
Health Care Needs Effective Reforms, Not the CREATES Act
Congress is back in session. With the election looming, this means a frenetic dash to pass bills on a number of big ticket items, including the budget and Zika funding. While the legislative fight over these issues will likely dominate the headlines, we cannot forget about other below-the-radar, but nevertheless ...
California
The high price of “cheap” drugs
California is losing the battle against opioid addiction. Every 45 minutes, someone in the Golden State overdoses. Fifty percent more people overdose today than in 2006. Fortunately, the Food and Drug Administration just approved the anti-addiction treatment Probuphine. It’s an implant placed in a person’s upper arm, where it releases ...
Business & Economics
Improving the Incentive to Innovate
PRI Releases New Brief on the Benefits of Improving Incentives for Health Care Innovations San Francisco, June 22, 2015 – The Pacific Research Institute, a non-partisan, non-profit think tank based in San Francisco, today announced the release of a new brief: “Improving the Incentive to Innovate: An Important Benefit of ...
Commentary
Empowering Frivolous Healthcare Litigation Does Not Help Patients
Of all the problems troubling the U.S. healthcare system, too little litigation is not one of them. And yet, the “Creating and Restoring Equal Access to Equivalent Samples Act of 2016” (CREATES Act), which is currently being rushed through Congress, takes just such an approach. If implemented, the CREATES Act ...
Commentary
Medicare Drug Reimbursement Cuts Are Backdoor Rationing
Imagine being denied treatment for cancer because Washington bureaucrats decided that a cutting-edge new therapy that could cure you just wasn’t “cost effective.” That’s already happening in Britain under its government-run health care system, the National Health Service. And Medicare officials are poised to bring similar policies here. The NHS’s ...
Commentary
Putting Cost Ahead of Medical Outcomes
Unlike most markets, prices do not convey value in health care. In light of this problem, the Boston-based Institute for Clinical and Economic Review has been attempting to calculate the value of new medical technologies in order to assign a reasonable price to the latest innovations. The Blue Shield of ...
Commentary
Trump’s Healthcare Plan: Right Diagnosis, Wrong Prescription
Donald Trump recently released a healthcare reform plan. If only he had spent as much time crafting it as he does his hair. The GOP frontrunner is right that Obamacare has failed to fix what ails America’s healthcare system. As Trump put it, the Affordable Care Act has “tragically but ...
Commentary
Donald Trump’s Obamacare Alternative Isn’t Bad, But It Isn’t Great Either
“Repeal and replace with something terrific.” That was Donald Trump’s promise for how he’d deal with Obamacare shortly after he announced his candidacy in June. Trump has finally revealed just what he meant by “terrific.” Last week, he released a seven-point plan outlining his alternative to Obamacare. Trump calls it ...
Commentary
Hillary’s Price Controls Would Kill New Drug Innovation
Like your iPhone? Federal officials designed it. Couldn’t live without the Internet? Thank Uncle Sam — he invented it. Sick and need new medicine? Don’t worry — the government is here to help. This fantastical line of thinking — that because the government funded basic, early-stage research, it can claim ...
Trump And Clinton’s Healthcare Debate Was No Contest
Donald Trump’s penchant for brusque remarks came in handy during the second presidential debate, eight days ago. When the discussion turned to the president’s health law, the GOP candidate’s message was clear: “Obamacare is a disaster. You know it. We all know it.” Only Hillary’s own spouse put it better, ...
Health Care Needs Effective Reforms, Not the CREATES Act
Congress is back in session. With the election looming, this means a frenetic dash to pass bills on a number of big ticket items, including the budget and Zika funding. While the legislative fight over these issues will likely dominate the headlines, we cannot forget about other below-the-radar, but nevertheless ...
The high price of “cheap” drugs
California is losing the battle against opioid addiction. Every 45 minutes, someone in the Golden State overdoses. Fifty percent more people overdose today than in 2006. Fortunately, the Food and Drug Administration just approved the anti-addiction treatment Probuphine. It’s an implant placed in a person’s upper arm, where it releases ...
Improving the Incentive to Innovate
PRI Releases New Brief on the Benefits of Improving Incentives for Health Care Innovations San Francisco, June 22, 2015 – The Pacific Research Institute, a non-partisan, non-profit think tank based in San Francisco, today announced the release of a new brief: “Improving the Incentive to Innovate: An Important Benefit of ...
Empowering Frivolous Healthcare Litigation Does Not Help Patients
Of all the problems troubling the U.S. healthcare system, too little litigation is not one of them. And yet, the “Creating and Restoring Equal Access to Equivalent Samples Act of 2016” (CREATES Act), which is currently being rushed through Congress, takes just such an approach. If implemented, the CREATES Act ...
Medicare Drug Reimbursement Cuts Are Backdoor Rationing
Imagine being denied treatment for cancer because Washington bureaucrats decided that a cutting-edge new therapy that could cure you just wasn’t “cost effective.” That’s already happening in Britain under its government-run health care system, the National Health Service. And Medicare officials are poised to bring similar policies here. The NHS’s ...
Putting Cost Ahead of Medical Outcomes
Unlike most markets, prices do not convey value in health care. In light of this problem, the Boston-based Institute for Clinical and Economic Review has been attempting to calculate the value of new medical technologies in order to assign a reasonable price to the latest innovations. The Blue Shield of ...
Trump’s Healthcare Plan: Right Diagnosis, Wrong Prescription
Donald Trump recently released a healthcare reform plan. If only he had spent as much time crafting it as he does his hair. The GOP frontrunner is right that Obamacare has failed to fix what ails America’s healthcare system. As Trump put it, the Affordable Care Act has “tragically but ...
Donald Trump’s Obamacare Alternative Isn’t Bad, But It Isn’t Great Either
“Repeal and replace with something terrific.” That was Donald Trump’s promise for how he’d deal with Obamacare shortly after he announced his candidacy in June. Trump has finally revealed just what he meant by “terrific.” Last week, he released a seven-point plan outlining his alternative to Obamacare. Trump calls it ...
Hillary’s Price Controls Would Kill New Drug Innovation
Like your iPhone? Federal officials designed it. Couldn’t live without the Internet? Thank Uncle Sam — he invented it. Sick and need new medicine? Don’t worry — the government is here to help. This fantastical line of thinking — that because the government funded basic, early-stage research, it can claim ...
